Literature DB >> 20959345

Perceived barriers to guidelines in peritoneal dialysis.

Nathan Allen1, Daniel Schwartz, Amy R Sood, David Mendelssohn, Mauro Verrelli, Gemini Tanna, Jeff Schiff, Paul Komenda, Claudio Rigatto, Manish M Sood.   

Abstract

BACKGROUND: Little is known regarding barriers to guideline adherence in the nephrology community. We set out to identify perceived barriers to evidence-based medicine (EBM) and measurement of continuous quality indicators (CQI) in an international cohort of peritoneal dialysis (PD) practitioners.
METHODS: Subscribers to an online nephrology education site (Nephrology Now) were invited to participate in an online survey. Nephrology Now is a non-profit, monthly mailing list that highlights clinically relevant articles in nephrology. Four hundred and seventy-five physicians supplying PD care participated in an online survey assessing their use of EBM and CQI in their PD practice. Ordinal logistic regression was utilized to determine relationships between baseline characteristics and EBM and CQI practices.
RESULTS: The majority of physicians were nephrologists (89.7%), and 50.4% worked in an academic centre. Respondents were from the following geographic regions: 13.5% Canadian, 24% American, 23.8% European, 4.4% Australian, 5.3% South American, 10.7% African and 12.2% Asian. Adherence to PD clinical practice guidelines were generally strong; however, lower adherence was associated with countries with lower healthcare expenditure, not using personal digital assistant (PDA), the longer the physician had been practising and smaller (< 20 patients per centre) PD practice.
CONCLUSIONS: International variation in guideline adherence may be influenced by a country's healthcare expenditure, physician's PDA use and experience, and size of PD practice which may impact future guideline development and implementation.

Entities:  

Mesh:

Year:  2010        PMID: 20959345     DOI: 10.1093/ndt/gfq623

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Knowledge, attitudes, and practices with regard to PD access: a report from the Peritoneal Dialysis Access Subcommittee of the Ontario Renal Network Committee on Independent Dialysis.

Authors:  Benjamin Shiff; Andreas Pierrato; Matthew J Oliver; Arsh K Jain; Brendan McCormick; Gokulan Kandasamy; Jeffrey Perl
Journal:  Perit Dial Int       Date:  2014 Nov-Dec       Impact factor: 1.756

2.  The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): Unifying Efforts to Inform Practice and Improve Global Outcomes in Peritoneal Dialysis.

Authors:  Jeffrey Perl; Simon J Davies; Mark Lambie; Ronald L Pisoni; Keith McCullough; David W Johnson; James A Sloand; Sarah Prichard; Hideki Kawanishi; Francesca Tentori; Bruce M Robinson
Journal:  Perit Dial Int       Date:  2015-11-02       Impact factor: 1.756

3.  Geographic and facility-level variation in the use of peritoneal dialysis in Canada: a cohort study.

Authors:  Manish M Sood; Navdeep Tangri; Brett Hiebert; Joanne Kappel; Allison Dart; Adeera Levin; Braden Manns; Anita Molzahn; David Naimark; Sharon J Nessim; Claudio Rigatto; Steven D Soroka; Michael Zappitelli; Paul Komenda
Journal:  CMAJ Open       Date:  2014-03-27

4.  International practice patterns and factors associated with non-conventional hemodialysis utilization.

Authors:  Nathan Allen; Daniel Schwartz; Paul Komenda; Robert P Pauly; Deborah Zimmerman; Gemini Tanna; Jeffery Schiff; Claudio Rigatto; Manish M Sood
Journal:  BMC Nephrol       Date:  2011-12-05       Impact factor: 2.388

5.  Challenges for Peritoneal Dialysis Centers Before and During the COVID-19 Pandemic in Mexico.

Authors:  Diana Perez-Moran; Ricardo Perez-Cuevas; Svetlana V Doubova
Journal:  Arch Med Res       Date:  2022-04-29       Impact factor: 8.323

6.  Where Are You Going, Nephrology? Considerations on Models of Care in an Evolving Discipline.

Authors:  Giorgina Barbara Piccoli; Conrad Breuer; Gianfranca Cabiddu; Angelo Testa; Christelle Jadeau; Giuliano Brunori
Journal:  J Clin Med       Date:  2018-08-03       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.